Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7760
Reference
Drug alert 51/2022
Name
Drug alert class 4 – 51 2022 – Class 4 medicines defect information - caution in use – Galderma Limited - Etrivex 500 micrograms/g shampoo
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
MEDICINES RECALL
Description
Galderma (U.K.) Limited has informed the MHRA that the patient information leaflet (PIL) packaged in specific batches of Etrivex Shampoo is missing the following safety information: Section 2: What you need to know before you use Etrivex 500 micrograms/g shampoo Warnings and Precautions: Contact your doctor if you experience blurred vision or other visual disturbances. Section 4: Possible side effects Etrivex shampoo may cause the following side effects: Not known (frequency cannot be estimated from the available data) - Blurred vision
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2022-12-06 00:00:00
Click to go back to homepage